JW Pharmaceutical Revenue

JW Pharmaceutical had revenue of 178.66B KRW in the quarter ending September 30, 2024, a decrease of -3.01%. This brings the company's revenue in the last twelve months to 736.54B, down -0.02% year-over-year. In the year 2023, JW Pharmaceutical had annual revenue of 748.53B with 9.38% growth.

Revenue (ttm)

736.54B

Revenue Growth

-0.02%

P/S Ratio

1.80

Revenue / Employee

692.24M

Employees

1,064

Market Cap

580.14B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	748.53B	64.18B	9.38%
Dec 31, 2022	684.35B	77.77B	12.82%
Dec 31, 2021	606.58B	59.25B	10.83%
Dec 31, 2020	547.34B	36.00B	7.04%
Dec 31, 2019	511.34B	-25.85B	-4.81%
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro
Dec 31, 2014	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	4,364.39B
Celltrion	2,876.25B
Yuhan	2,008.84B
SK Biopharmaceuticals	511.33B
SK bioscience	201.30B
Hanmi Pharm.	1,495.50B
Peptron	2.41B
Hanall Biopharma	134.24B

Revenue Rankings